cagrilintide semaglutide combination cagrisema phase 3 2025 results Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double Cagrilintide Weight Loss: Results, Dosing

There is now robust evidence to show that sodium glucose co-transporter 2 inhibitors (SGLT2i) give lower rates of HF hospitalisation in people with T2DM with or at high risk of CV disease

The truth is that Wegovy costs vary dramatically depending on your insurance status, province of residence, and pharmacy choice

The accuracy of a fibromyalgia diagnosis in general practice

Price transparency and what each includes The sharpest practical difference here is disclosure

The percentage of workers at California firms offering health benefits who are covered by their firms health plan is similar to 2022 (60%)

Circuits controlling vertebrate locomotion: moving in a new direction